Search
for
Sort by
Research 511–540 of 1000+
- EP1446 - ECE_2942 - Finasteride for treatment of androgenic male alopecia since puberty: case report
- Impact of 5-alpha Reductase Inhibitors on Male Reproductive Health: A Review of Finasteride and Dutasteride.
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Post-finasteride syndrome: survey of dermatologists from the Spanish Hair and Nail Disorders Group
- Use of finasteride and minoxidil for the treatment of androgenetic alopecia: a review
- Uso de finasterida e minoxidil para o tratamento da alopecia androgenética: uma revisão
- Evaluation of residual symptoms and anxiety among patients on therapy for benign prostatic hyperplasia at a Nigerian tertiary healthcare facility
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- COMPLICAÇÕES DOS TRATAMENTOS DA ALOPÉCIA ANDROGÉNICA: REVISÃO SISTEMÁTICA E META-ANÁLISE
- Battling a receding tide: Treatment for androgenic alopecia
- Farmácia Avenida - Guimarães e nos Serviços Farmacêuticos da Unidade Local de Saúde do Alto Ave, EPE - Guimarães
- Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- Finasteride in Young Men: Effects on Semen and Hormones?
- Male pattern hair loss
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review
- The manosphere and men's health: unpacking the links between online communities, body dysmorphia and erectile dysfunction
- Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort
- Fetal gender: preferences, predictions, and its impact on women's sexuality, physical activity, and well-being during pregnancy
- Vergleichende Studie zur sexuellen Dysfunktion bei Alopecia areata: Prävalenz und assoziierte Faktoren
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Post‐finasteride syndrome: real or myth?
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?
- Patient‐reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
- Sertoli-Leydig tumor in a 17-year-old girl: a case report
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Toxoplasma gondii infection and testosterone alteration: A systematic review and meta-analyses